+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Asia Pacific Sclerotherapy Market By Agent (Detergents, Osmotic Agents and Chemical Irritants), By Type (Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy), By Country, Industry Analysis and Forecast, 2020 - 2026

  • ID: 5185465
  • Report
  • October 2020
  • Region: Asia Pacific
  • 57 pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
The Asia Pacific Sclerotherapy Market is expected to witness market growth of 9.3% CAGR during the forecast period (2020-2026).

The sclerotherapy is usually used to treat spider veins, haemorrhoids, and smaller varicose veins in adults. In Sclerotherapy, a very fine and thin injection needle is used to inject solution in order to treat small varicose veins in the legs, improve the appearance of spider veins, and get rid of related symptoms like burning, aching, swelling and cramping. Dermatologists have played an important role in the advancement of new safe, and non-invasive technologies that can be use in the treatment of both larger varicose veins, and cosmetic telangiectasias and procedure has become a medical significance. The major advancements have been made in sclerosing solutions, and endovascular RF and laser procedures and they have brought a revolution in the healthcare industry.

Varicose veins and telangiectasias if left untreated, they can cause severe health problems like deep vein clots, skin ulcers, chronic pain, and coronary ailments. According to NCBI, more than 20.0% of all adults suffer from varicose veins at some point or the other time in their lives and the occurrence is higher among the elderly population and women. These factors are likely to lift the market growth. Though, the side effects of this procedure including hyperpigmentation, scarring, matting, and allergic reactions in some patients are expected to hinder the market growth.

Based on Agent, the market is segmented into Detergents, Osmotic Agents and Chemical Irritants. Based on Type, the market is segmented into Liquid Sclerotherapy, Ultrasound Sclerotherapy and Foam Sclerotherapy. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Perrigo Company PLC (Omega Pharmaceuticals), Cook Medical, Inc. (Cook Group), Chemische Fabrik Kreussler & Co. GmbH, LGM Pharma, LLC, Troikaa Pharmaceuticals Limited, Tianyu Chang’an Group, Endo-Flex GmbH (Meditek Systems), Merz Pharma GmbH & Co. KGaA, and MTW-Endoskopie W. Haag KG.

Scope of the Study

Market Segmentation:

By Agent
  • Detergents
  • Osmotic Agents
  • Chemical Irritants
By Type
  • Liquid Sclerotherapy
  • Ultrasound Sclerotherapy
  • Foam Sclerotherapy
By Country
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
Companies Profiled
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • LGM Pharma, LLC
  • MTW-Endoskopie W. Haag KG
  • Tianyu Chang’an Group
  • MORE
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Sclerotherapy Market, by Agent
1.4.2 Asia Pacific Sclerotherapy Market, by Type
1.4.3 Asia Pacific Sclerotherapy Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.2 Market Composition and Scenario
2.3 Key Factors Impacting the Market
2.3.1 Market Drivers
2.3.2 Market Restraints

Chapter 3. Asia Pacific Sclerotherapy Market by Agent
3.1 Asia Pacific Detergents Market by Country
3.2 Asia Pacific Osmotic Agents Market by Country
3.3 Asia Pacific Chemical Irritants Market by Country

Chapter 4. Asia Pacific Sclerotherapy Market by Type
4.1 Asia Pacific Liquid Sclerotherapy Market by Country
4.2 Asia Pacific Ultrasound Sclerotherapy Market by Country
4.3 Asia Pacific Other Type Market by Country

Chapter 5. Asia Pacific Sclerotherapy Market by Country
5.1 China Sclerotherapy Market
5.1.1 China Sclerotherapy Market by Agent
5.1.2 China Sclerotherapy Market by Type
5.2 Japan Sclerotherapy Market
5.2.1 Japan Sclerotherapy Market by Agent
5.2.2 Japan Sclerotherapy Market by Type
5.3 India Sclerotherapy Market
5.3.1 India Sclerotherapy Market by Agent
5.3.2 India Sclerotherapy Market by Type
5.4 South Korea Sclerotherapy Market
5.4.1 South Korea Sclerotherapy Market by Agent
5.4.2 South Korea Sclerotherapy Market by Type
5.5 Singapore Sclerotherapy Market
5.5.1 Singapore Sclerotherapy Market by Agent
5.5.2 Singapore Sclerotherapy Market by Type
5.6 Malaysia Sclerotherapy Market
5.6.1 Malaysia Sclerotherapy Market by Agent
5.6.2 Malaysia Sclerotherapy Market by Type
5.7 Rest of Asia Pacific Sclerotherapy Market
5.7.1 Rest of Asia Pacific Sclerotherapy Market by Agent
5.7.2 Rest of Asia Pacific Sclerotherapy Market by Type

Chapter 6. Company Profiles
6.1 Boston Scientific Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.2 Perrigo Company PLC (Omega Pharmaceuticals)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Cook Medical, Inc. (Cook Group)
6.3.1 Company Overview
6.4 Chemische Fabrik Kreussler & Co. GmbH
6.4.1 Company Overview
6.5 LGM Pharma, LLC
6.5.1 Company Overview
6.6 Troikaa Pharmaceuticals Limited
6.6.1 Company Overview
6.7 Tianyu Chang’an Group
6.7.1 Company Overview
6.8 Endo-Flex GmbH (Meditek Systems)
6.8.1 Company Overview
6.9 Merz Pharma GmbH & Co. KGaA
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Partnerships, Collaborations, and Agreements:
6.10. MTW-Endoskopie W. Haag KG
6.10.1 Company Overview
Note: Product cover images may vary from those shown
3 of 4
  • Boston Scientific Corporation
  • Perrigo Company PLC (Omega Pharmaceuticals)
  • Cook Medical, Inc. (Cook Group)
  • Chemische Fabrik Kreussler & Co. GmbH
  • LGM Pharma, LLC
  • Troikaa Pharmaceuticals Limited
  • Tianyu Chang’an Group
  • Endo-Flex GmbH (Meditek Systems)
  • Merz Pharma GmbH & Co. KGaA
  • MTW-Endoskopie W. Haag KG
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll